AlvioLife (Terminalia bellirica, Boswellia serrata)

AlvioLife combines Terminalia bellirica tannins with Boswellia serrata boswellic acids to target respiratory inflammation through 5-lipoxygenase inhibition. This patented blend demonstrates clinically proven improvements in lung function and capacity in pollution-sensitive individuals.

Origin & History

AlvioLife (LI13109F) is a standardized herbal composition containing extracts of Boswellia serrata gum resin and Aegle marmelos fruit, designed to deliver consistent levels of bioactive compounds, particularly boswellic acids. The extraction and standardization methods ensure reproducible composition for clinical and commercial applications.

Historical & Cultural Context

The research dossier does not provide historical context regarding traditional medicine use of Boswellia serrata or Aegle marmelos. AlvioLife appears to be a modern standardized formulation rather than a traditional preparation.

Health Benefits

• Improves lung function by 16% and lung capacity by 30% within 6 weeks in adults with air pollution sensitivity (randomized controlled trial, n=105)
• Significantly improves quality of life scores in mild to moderate asthma patients within 14 days (clinical trial evidence)
• Reduces airway inflammation by decreasing infiltrated granulocyte population in broncho-alveolar lavage fluid (peer-reviewed study)
• Normalizes Th1/Th2 cytokine balance and modulates immune markers including CD4+ T cells and interferon-γ (clinical evidence)
• Inhibits 5-lipoxygenase pathway and human leukocyte elastase, key mechanisms in respiratory conditions (mechanistic studies)

How It Works

AlvioLife's boswellic acids from Boswellia serrata inhibit 5-lipoxygenase enzyme, reducing leukotriene production and airway inflammation. Terminalia bellirica tannins provide additional anti-inflammatory effects through NF-κB pathway modulation. This dual-action approach targets both acute inflammatory responses and chronic airway remodeling processes.

Scientific Research

A 2023 randomized, double-blind, placebo-controlled study (n=105) demonstrated significant respiratory improvements with 200mg daily AlvioLife supplementation. A peer-reviewed study (PMID: 29210124) evaluated LI13109F in asthma management, showing significant reduction in airway inflammation with no serious adverse events.

Clinical Summary

A randomized controlled trial with 105 adults showed AlvioLife improved lung function by 16% and lung capacity by 30% within 6 weeks in pollution-sensitive individuals. Clinical evidence demonstrates significant quality of life improvements in mild to moderate asthma patients within 14 days of supplementation. The studies specifically focused on respiratory outcomes, though sample sizes remain moderate. Evidence is promising but limited to short-term respiratory benefits.

Nutritional Profile

AlvioLife is a proprietary standardized herbal combination extract, not a conventional food ingredient, so macronutrient and micronutrient content is not the primary characterization. Key bioactive compounds and concentrations include: Terminalia bellirica component - standardized to contain tannins including chebulagic acid, chebulinic acid, ellagic acid, gallic acid (typically 20-40% total tannins by dry weight in standardized extracts); bellericaside and bellericoside (triterpene glycosides, approximately 2-5% in standardized extracts); beta-sitosterol and other phytosterols (~0.5-1%); fixed oils including linoleic and oleic acid in fruit. Boswellia serrata component - standardized to boswellic acids (AKBA - 3-O-acetyl-11-keto-beta-boswellic acid is the primary active, typically 10-30% total boswellic acids in standardized extracts); AKBA concentration specifically targeted at ~30% in high-potency extracts; alpha- and beta-boswellic acids, 11-keto-beta-boswellic acid also present. Fiber content: moderate polysaccharide content from Terminalia bellirica fruit (~15-25% of dry fruit weight). Protein: minimal (<5%). Vitamins: Terminalia bellirica contains trace Vitamin C (ascorbic acid, ~10-20 mg/100g dried fruit). Minerals: trace calcium, iron, phosphorus from plant matrix. Bioavailability notes: AKBA from Boswellia serrata has poor oral bioavailability (~1-3%) when unformulated due to lipophilicity; formulation with phospholipids or piperine can enhance absorption by 2-3x. Tannins from Terminalia bellirica may complex with proteins and minerals, reducing co-administered mineral absorption. Specific AlvioLife proprietary formulation ratios and standardization specifications are not fully publicly disclosed beyond clinical trial references.

Preparation & Dosage

The clinically studied dosage is 200 mg daily of standardized AlvioLife formulation (LI13109F). This dose showed significant respiratory improvements within 6 weeks in clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, N-Acetyl Cysteine, Vitamin D3, Cordyceps, Bromelain

Safety & Interactions

AlvioLife is generally well-tolerated with minimal reported side effects in clinical studies. Boswellia serrata may interact with anticoagulant medications due to potential blood-thinning effects. Individuals with tree nut allergies should exercise caution with Terminalia bellirica. Pregnant and breastfeeding women should avoid use due to insufficient safety data for these populations.